Literature DB >> 575417

Blockade of pressor responses to angiotensins I and II and noradrenaline using phentolamine, propranolol and hexamethonium in conscious rabbits.

B P Rowe, A R Noble, K A Munday.   

Abstract

Angiotensin I is known to have direct agonist activity at some target tissues, independent of its conversion to angiotensin II. Aspects of its possible direct role as a pressor agent were investigated in conscious rabbits. Phentolamine (3 mg/kg i.v.), a dose which did not affect baseline blood pressure, reduced the pressor response to angiotensin II by 17% (P less than 0.05) but did not alter the sensitivity to angiotensin I. Noradrenaline activity was reduced by 56%. Propranolol (2 mg/kg i.v.), a dose which did not affect baseline blood pressure but which substantially reduced the depressor response to isoprenaline, had no effect on the pressor activity of either angiotensin I or II. Noradrenaline potency was reduced by 32%. Hexamethonium (20 mg/kg i.v.), caused a potentiation of the response to angiotensin I and II and noradrenaline. This was probably a non-specific action associated with the decrease in baseline blood pressure. No differential effect of ganglion blockade on the two angiotensins was noted. The dissociation of the effects of phentolamine on angiotensins I and II provides further evidence that pressor actions of these two compounds act through partially different mechanisms.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 575417     DOI: 10.1007/bf00583712

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  23 in total

Review 1.  Renin-angiotensin system: biochemistry and mechanisms of action.

Authors:  M J Peach
Journal:  Physiol Rev       Date:  1977-04       Impact factor: 37.312

Review 2.  Central vasopressor actions of angiotensin.

Authors:  J P Buckley
Journal:  Biochem Pharmacol       Date:  1977-01-01       Impact factor: 5.858

3.  Angiotensin tachyphylaxis in guinea-pig aortic strips.

Authors:  D Palaic; P Lemorvan
Journal:  J Pharmacol Exp Ther       Date:  1971-12       Impact factor: 4.030

Review 4.  Pharmacology of angiotensin.

Authors:  D Regoli; W K Park; F Rioux
Journal:  Pharmacol Rev       Date:  1974-06       Impact factor: 25.468

5.  Reduction of pressor effects of angiotensin I in man by synthetic nonapeptide (B.P.P. 9a or SQ 20,881) which inhibits converting enzyme.

Authors:  J G Collier; B F Robinson; J R Vane
Journal:  Lancet       Date:  1973-01-13       Impact factor: 79.321

6.  Effect of angiotensin on vascular smooth muscles.

Authors:  P Walter; E Bassenge
Journal:  Pflugers Arch       Date:  1969       Impact factor: 3.657

7.  Studies on the mechanism of the vasoconstrictor effect of angiotensin II in man.

Authors:  G Johnsson; M Henning; B Ablad
Journal:  Life Sci       Date:  1965-08       Impact factor: 5.037

8.  Cross-tachyphylaxis of the pressor response to angiotensins in conscious rabbits.

Authors:  B P Rowe; A R Noble; K A Munday
Journal:  Pflugers Arch       Date:  1979-05-15       Impact factor: 3.657

Review 9.  Receptors for angiotensin: a critical analysis.

Authors:  D Regoli
Journal:  Can J Physiol Pharmacol       Date:  1979-02       Impact factor: 2.273

10.  The effect of reserpine on the pressor responses to angiotensin in the conscious cat.

Authors:  M D Day; D A Owen
Journal:  Br J Pharmacol       Date:  1970-06       Impact factor: 8.739

View more
  1 in total

1.  The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure.

Authors:  Christophe Guilluy; Jérémy Brégeon; Gilles Toumaniantz; Malvyne Rolli-Derkinderen; Kevin Retailleau; Laurent Loufrani; Daniel Henrion; Elizabeth Scalbert; Antoine Bril; Raul M Torres; Stephan Offermanns; Pierre Pacaud; Gervaise Loirand
Journal:  Nat Med       Date:  2010-01-24       Impact factor: 53.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.